pmVenus-C2-MmMKL2
(Plasmid
#67894)
-
PurposeExpresses a fusion of mVenus with MKL2 (MRTF-B) in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 67894 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEGFP-C1
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 4000
- Total vector size (bp) 7979
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemVenus-MKL2
-
Alt namemVenus-MRTF-B
-
SpeciesM. musculus (mouse), Synthetic
-
Insert Size (bp)4029
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AgeI (not destroyed)
- 3′ cloning site KpnI (not destroyed)
- 5′ sequencing primer CMV (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThis plasmid is modified from pEGFP-MRTF-B, originally reported by Hinson et al. (2007) (https://www.ncbi.nlm.nih.gov/pubmed/16997888)
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pmVenus-C2-MmMKL2 was a gift from Dorus Gadella (Addgene plasmid # 67894 ; http://n2t.net/addgene:67894 ; RRID:Addgene_67894) -
For your References section:
Plasma membrane restricted RhoGEF activity is sufficient for RhoA-mediated actin polymerization. van_Unen J, Reinhard NR, Yin T, Wu YI, Postma M, Gadella TWJ and Goedhart J . Scientific Reports 5, Article number: 14693 (2015) doi:10.1038/srep14693